Presentation_1_Novel Anti-Interleukin-1β Therapy Preserves Retinal Integrity: A Longitudinal Investigation Using OCT Imaging and Automated Retinal Segmentation in Small Rodents.pptx
Retinopathy of prematurity (ROP) is the leading cause of blindness in neonates. Inflammation, in particular interleukin-1β (IL-1β), is increased in early stages of the disorder, and contributes to inner and outer retinal vasoobliteration in the oxygen-induced retinopathy (OIR) model of ROP. A small peptide antagonist of IL-1 receptor, composed of the amino acid sequence, rytvela, has been shown to exert beneficial anti-inflammatory effects without compromising immunovigilance-related NF-κB in reproductive tissues. We conducted a longitudinal study to determine the efficacy of “rytvela” in preserving the integrity of the retina in OIR model, using optical coherence tomography (OCT) which provides high-resolution cross-sectional imaging of ocular structures in vivo. Sprague–Dawley rats subjected to OIR and treated or not with “rytvela” were compared to IL-1 receptor antagonist (Kineret). OCT imaging and custom automated segmentation algorithm used to measure retinal thickness (RT) were obtained at P14 and P30; gold-standard immunohistochemistry (IHC) was used to confirm retinal anatomical changes. OCT revealed significant retinal thinning in untreated animals by P30, confirmed by IHC; these changes were coherently associated with increased apoptosis. Both rytvela and Kineret subsided apoptosis and preserved RT. As anticipated, Kineret diminished both SAPK/JNK and NF-κB axes, whereas rytvela selectively abated the former which resulted in preserved monocyte phagocytic function. Altogether, OCT imaging with automated segmentation is a reliable non-invasive approach to study longitudinally retinal pathology in small animal models of retinopathy.
History
References
- https://doi.org//10.1364/BOE.6.001694
- https://doi.org//10.1038/s41598-018-30087-30084
- https://doi.org//10.1371/journal.pone.0099036
- https://doi.org//10.1167/iovs.07-0916
- https://doi.org//10.1007/s10633-009-9208-9203
- https://doi.org//10.1167/tvst.4.4.9
- https://doi.org//10.3389/fchem.2019.00023
- https://doi.org//10.1038/sj.onc.1209943
- https://doi.org//10.1186/1476-4598-12-86
- https://doi.org//10.1038/nm.3669
- https://doi.org//10.1371/journal.pone.0132804
- https://doi.org//10.1016/j.immuni.2012.10.014
- https://doi.org//10.1203/01.pdr.0000176836.27156.32
- https://doi.org//10.1038/srep42112
- https://doi.org//10.1086/422330
- https://doi.org//10.4049/jimmunol.1500758
- https://doi.org//10.1002/path.4403
- https://doi.org//10.1203/00006450-199412000-199412007
- https://doi.org//10.4049/jimmunol.180.10.6977
- https://doi.org//10.7860/JCDR/2013/6170.3541
- https://doi.org//10.1186/s12974-017-0943-941
- https://doi.org//10.1161/ATVBAHA.113.301331
- https://doi.org//10.1016/j.ajpath.2014.10.020
- https://doi.org//10.1016/j.freeradbiomed.2016.08.013
- https://doi.org//10.1016/j.ajpath.2016.08.004
- https://doi.org//10.1167/iovs.16-20526